Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)Product type:GuidanceProgramme:Health technology evaluationPublished: 28 September 2023
Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812Status:Topic selectionProgramme:Health technology evaluationExpected publication date: TBC